Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
NCT01848873 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 756
Last updated 2013-05-08
Summary
To evaluate the efficacy of Amlodipine-folic Acid Tablets on reduction of blood pressure and plasma homocystein.
Conditions
- Essential Hypertension
Interventions
- DRUG
-
Amlodipine
amlodipine 5mg daily
- DRUG
-
amlodipine-FA tablet, low dose group
5mg amlodipine combined with 0.4 mg of folic acid, daily.
- DRUG
-
amlodipine-FA tablet ,high dose group
amlodipine 5mg and folic acid 0.8mg daily
Sponsors & Collaborators
-
Peking University First Hospital
collaborator OTHER -
Chinese PLA General Hospital
collaborator OTHER -
Capital Medical University
collaborator OTHER -
Fudan University
collaborator OTHER -
Ruijin Hospital
collaborator OTHER -
Nanchang University
collaborator OTHER -
First Affiliated Hospital of Fujian Medical University
collaborator OTHER -
First Affiliated Hospital of Harbin Medical University
collaborator OTHER -
China Medical University, China
collaborator OTHER -
Xi'an Jiaotong University
collaborator OTHER -
Xuzhou Medical University
collaborator OTHER -
Anhui Medical University
collaborator OTHER -
Huazhong University of Science and Technology
collaborator OTHER -
West China Hospital
collaborator OTHER -
Guangdong Provincial People's Hospital
collaborator OTHER -
Second Affiliated Hospital, School of Medicine, Zhejiang University
collaborator OTHER -
Shenzhen Ausa Pharmed Co.,Ltd
lead INDUSTRY
Principal Investigators
-
Yong Huo, MD · Peking University First Hospital, Beijing, CHINA
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2013-08-31
- Completion
- 2013-08-31
Countries
- China
Study Locations
More Related Trials
-
Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine
NCT00626743 ·Status: COMPLETED ·Phase: PHASE1
-
Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension
NCT05165251 ·Status: UNKNOWN ·Phase: PHASE4
-
Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient
NCT00443456 ·Status: COMPLETED ·Phase: PHASE3
-
DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension
NCT01614366 ·Status: COMPLETED ·Phase: PHASE2
-
Amlodipine Prevents Morning Blood Pressure Surge Study
NCT01030081 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy
NCT00666536 ·Status: COMPLETED ·Phase: PHASE4
-
Telmisartan, Amlodipine and Combination in Healthy Subjects
NCT01181011 ·Status: COMPLETED ·Phase: PHASE1
-
Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension
NCT00527514 ·Status: COMPLETED ·Phase: PHASE3
-
To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone
NCT01070043 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension
NCT00289406 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients
NCT00627952 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg
NCT00687973 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
NCT00548067 ·Status: COMPLETED ·Phase: PHASE3
-
N-of-1 Trials for Blood Pressure Medications in Adults
NCT02744456 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient
NCT00415623 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate
NCT01845272 ·Status: UNKNOWN ·Phase: PHASE1
-
Amlodipine Plus/Minus Atorvastatin for Protection of Arteries
NCT01922687 ·Status: UNKNOWN ·Phase: PHASE4
-
Telmisartan+Amlodipine Fixed Dose Combination in Hypertension
NCT01204398 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension
NCT02969265 ·Status: WITHDRAWN ·Phase: PHASE3
-
Comparision of Blood Pressure Variability Between Amlodipine and Losartan
NCT01964079 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension
NCT00940667 ·Status: COMPLETED ·Phase: PHASE3
-
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
NCT03264352 ·Status: RECRUITING ·Phase: PHASE4
-
The Pharmacokinetic Interaction Between Amlodipine and Losartan
NCT03912285 ·Status: COMPLETED ·Phase: PHASE1
-
Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness
NCT02940548 ·Status: TERMINATED ·Phase: PHASE4
-
Low-dose Quadruple Combination Therapy in Patients With Hypertension
NCT05377203 ·Status: COMPLETED ·Phase: PHASE4